Innate Pharma Quote - IPH

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.924

Bid

1.916

Offer

1.96

Volume

112,636

1.90 Day's Range 2.00

1.332 52 Week Range 2.80

Market Cap

612.16M

Previous Close

2.01

Open

2.00

Last Trade

383

1.924

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

141,200

Shares Outstanding

318,170,508

Dividend Yield

PE Ratio

-80.67

Earnings Per Share (EPS)

-0.02

Revenue

61.64M

Net Profit

-7.57M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 2.01 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.80 €.

Innate Pharma currently has 318,170,508 shares in issue. The market capitalisation of Innate Pharma is 639.52 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -80.67.

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P...

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

Findings reveal promising early signs that lacutamab may help alleviate some of the most distressing symptoms of cutaneous T cell lymphomas Regulatory News: Innate Pharma SA (Euronext Paris:...

Innate Pharma et l’Institut d’Innovation pour le Lymphome Folliculaire (IFLI) annoncent un investissement jusqu’à 7,9 millions de dollars de l’IFLI pour soutenir le développement d’IPH6501 dans le lymphome folliculaire

Innate recevra 3 millions de dollars en paiement initial et jusqu’à 4,9 millions de dollars en tranches d’investissements conditionnelles de l’Institut d’Innovation pour le Lymphome Folliculaire...

Innate Pharma partage les présentations sélectionnées pour le congrès annuel de l’ASH 2024

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des abstracts concernant les données portant sur la qualité de vie...

Innate Pharma Releases Its 2025 Financial Calendar

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2025 financial calendar: March 27, 2025: Publication of 2024 financial...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.392	25.5874673629	1.532	2.49	1.39	515164	2.05271259	DE
4	0.4	26.2467191601	1.524	2.49	1.332	267786	1.80648036	DE
12	-0.076	-3.8	2	2.49	1.332	141200	1.76420878	DE
26	-0.156	-7.5	2.08	2.49	1.332	87251	1.83763636	DE
52	-0.546	-22.1052631579	2.47	2.8	1.332	86656	2.1241205	DE
156	-2.376	-55.2558139535	4.3	4.73	1.332	137884	2.74181208	DE
260	-3.681	-65.6735057984	5.605	7.48	1.332	253534	3.89499786	DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?

The current share price of Innate Pharma is 1.924 €

How many Innate Pharma shares are in issue?

Innate Pharma has 318,170,508 shares in issue

What is the market cap of Innate Pharma?

The market capitalisation of Innate Pharma is EUR 639.52M

What is the 1 year trading range for Innate Pharma share price?

Innate Pharma has traded in the range of 1.332 € to 2.80 € during the past year

What is the PE ratio of Innate Pharma?

The price to earnings ratio of Innate Pharma is -80.67

What is the cash to sales ratio of Innate Pharma?

The cash to sales ratio of Innate Pharma is 9.91

What is the reporting currency for Innate Pharma?

Innate Pharma reports financial results in EUR

What is the latest annual turnover for Innate Pharma?

The latest annual turnover of Innate Pharma is EUR 61.64M

What is the latest annual profit for Innate Pharma?

The latest annual profit of Innate Pharma is EUR -7.57M

What is the registered address of Innate Pharma?

The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009

What is the Innate Pharma website address?

The website address for Innate Pharma is www.innate-pharma.com

Which industry sector does Innate Pharma operate in?

Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TMBSZTME Pharma NV	0.02 € (185.71%)	132.5k
MLGEQGentlemen S Equity SA	0.0175 € (118.75%)	1.14k
ALCYBCybergun	0.0002 € (100.00%)	17.54M
MLAAHAmatheon Agri Holding NV	0.0185 € (54.17%)	40.1k
ALARFAdeunis	0.94 € (28.77%)	5.27k
MLSMLSmalto	0.0125 € (-37.50%)	2.34k
MLFTIFrance Tourisme Immobilier	0.025 € (-35.90%)	56.77k
CNVCnova NV	0.209 € (-19.62%)	26.38k
MLWEAWeaccess Group	0.382 € (-16.96%)	5.95k
ALEUPEuroplasma	0.0353 € (-15.95%)	3.16M
ATOAtos SE	0.0021 € (0.00%)	2.71B
BCPBanco Comercial Portugues SA	0.4493 € (-0.69%)	66.54M
ALHGLouis Hachette Group	1.3342 € (4.87%)	52.04M
KPNKoninklijke KPN NV	3.509 € (-1.21%)	26.9M
VIVVivendi SE	2.51 € (2.41%)	26.39M